abstract |
The invention relates to the use of dopamine autoreceptor agonists, in particular of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine (BHT 920) and (S)-2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole (SND 919), for producing medicaments for the treatment of drug dependency. |